Lifecore Biomedical: Fiscal Q2 Earnings Snapshot
Lifecore Biomedical: Fiscal Q2 Earnings Snapshot
Lifecore Biomedical Selected by Nirsum Laboratories to Provide CDMO Services for NRS-033 Clinical Development
Lifecore will provide CDMO services for Nirsum's clinical development of NRS-033, targeting opioid and alcohol use disorders.Quiver AI SummaryLifecore Biomedical, Inc. has been selected by Nirsum Laboratories,...
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Lifecore Biomedical Secures Three-Year Extension of Credit Facility with BMO, Enhancing Financial Stability and Growth Opportunities
Lifecore Biomedical extends credit terms, reducing interest rates, enhancing financial stability, and supporting its growth strategy.Quiver AI SummaryLifecore Biomedical, Inc. announced a three-year extension...
Lifecore Biomedical, Inc. Hosts Virtual Investor Day to Discuss Future Growth Strategies
Lifecore Biomedical hosted a virtual investor day discussing growth strategies and company updates, with a replay available online.Quiver AI SummaryLifecore Biomedical, Inc. announced the hosting of a...